학술논문
Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
Document Type
Article
Author
Lu, Shun; Wang, Qiming; Zhang, Guojun; Dong, Xiaorong; Yang, Cheng-Ta; Song, Yong; Chang, Gee-Chen; Lu, You; Pan, Hongming; Chiu, Chao-Hua; Wang, Zhehai; Feng, Jifeng; Zhou, Jianying; Xu, Xingxiang; Guo, Renhua; Chen, Jianhua; Yang, Haihua; Chen, Yuan; Yu, Zhuang; Shiah, Her-Shyong; Wang, Chin-Chou; Yang, Nong; Fang, Jian; Wang, Ping; Wang, Kai; Hu, Yanping; He, Jianxing; Wang, Ziping; Shi, Jianhua; Chen, Shaoshui; Wu, Qiong; Sun, Changan; Li, Chuan; Wei, Hongying; Cheng, Ying; Su, Wu-Chou; Hsia, Te-Chun; Cui, Jiuwei; Sun, Yuping; Ou, Sai-Hong Ignatius; Zhu, Viola W.; Chih-Hsin Yang, James
Source
In Journal of Thoracic Oncology March 2022 17(3):411-422
Subject
Language
ISSN
1556-0864